Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
10
SSKN Quote, Financials, Valuation and Earnings
Last price:
$0.26
Seasonality move
:
-3.35%
Day range:
$0.23 - $0.27
52-week range:
$0.12 - $3.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
1.01x
Volume:
52.4K
Avg. volume:
849.3K
1-year change:
-91.48%
Market cap:
$1.3M
Revenue:
$33.6M
EPS (TTM):
-$2.62
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SSKN
STRATA Skin Sciences, Inc.
|
$9.2M | -$0.26 | 9.37% | -75.88% | $7.40 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATRC
AtriCure, Inc.
|
$139.8M | -$0.04 | 12.89% | -57.61% | $49.38 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.8B | $2.27 | 16.31% | 10.87% | $609.82 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SSKN
STRATA Skin Sciences, Inc.
|
$0.23 | $7.40 | $1.3M | -- | $0.00 | 0% | 0.03x |
|
ABT
Abbott Laboratories
|
$114.12 | $133.39 | $198.3B | 30.70x | $0.63 | 2.1% | 4.50x |
|
ARAY
Accuray, Inc.
|
$0.55 | $2.53 | $65.5M | 149.00x | $0.00 | 0% | 0.14x |
|
ATRC
AtriCure, Inc.
|
$30.93 | $49.38 | $1.5B | -- | $0.00 | 0% | 2.76x |
|
ISRG
Intuitive Surgical, Inc.
|
$496.25 | $609.82 | $176.2B | 63.01x | $0.00 | 0% | 17.88x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.30 | $5.50 | $41.2M | -- | $0.00 | 0% | 4.80x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SSKN
STRATA Skin Sciences, Inc.
|
92.55% | 1.211 | 150.29% | 0.74x |
|
ABT
Abbott Laboratories
|
21.33% | 0.218 | 6.98% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.787 | 177.87% | 0.52x |
|
ATRC
AtriCure, Inc.
|
13.46% | 1.893 | 3.88% | 2.88x |
|
ISRG
Intuitive Surgical, Inc.
|
0.95% | 0.975 | 0.08% | 3.73x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -3.087 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SSKN
STRATA Skin Sciences, Inc.
|
$4.2M | -$1.9M | -54.88% | -296.68% | -26.8% | -$1.1M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATRC
AtriCure, Inc.
|
$104.6M | $3.5M | -2.09% | -2.44% | 2.49% | $18.4M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.53% | 16.59% | 30.16% | $730M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
STRATA Skin Sciences, Inc. vs. Competitors
-
Which has Higher Returns SSKN or ABT?
Abbott Laboratories has a net margin of -23.41% compared to STRATA Skin Sciences, Inc.'s net margin of 15.71%. STRATA Skin Sciences, Inc.'s return on equity of -296.68% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital SSKNSTRATA Skin Sciences, Inc.60.38% -$0.36 $17.6M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About SSKN or ABT?
STRATA Skin Sciences, Inc. has a consensus price target of $7.40, signalling upside risk potential of 4700%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 16.89%. Given that STRATA Skin Sciences, Inc. has higher upside potential than Abbott Laboratories, analysts believe STRATA Skin Sciences, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings SSKNSTRATA Skin Sciences, Inc.1 0 0 ABTAbbott Laboratories16 7 0 -
Is SSKN or ABT More Risky?
STRATA Skin Sciences, Inc. has a beta of 0.448, which suggesting that the stock is 55.193% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.741, suggesting its less volatile than the S&P 500 by 25.919%.
-
Which is a Better Dividend Stock SSKN or ABT?
STRATA Skin Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.1% to investors and pays a quarterly dividend of $0.63 per share. STRATA Skin Sciences, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSKN or ABT?
STRATA Skin Sciences, Inc. quarterly revenues are $6.9M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. STRATA Skin Sciences, Inc.'s net income of -$1.6M is lower than Abbott Laboratories's net income of $1.8B. Notably, STRATA Skin Sciences, Inc.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 30.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STRATA Skin Sciences, Inc. is 0.03x versus 4.50x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSKNSTRATA Skin Sciences, Inc.0.03x -- $6.9M -$1.6M ABTAbbott Laboratories4.50x 30.70x $11.5B $1.8B
-
Which has Higher Returns SSKN or ARAY?
Accuray, Inc. has a net margin of -23.41% compared to STRATA Skin Sciences, Inc.'s net margin of -13.47%. STRATA Skin Sciences, Inc.'s return on equity of -296.68% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital SSKNSTRATA Skin Sciences, Inc.60.38% -$0.36 $17.6M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About SSKN or ARAY?
STRATA Skin Sciences, Inc. has a consensus price target of $7.40, signalling upside risk potential of 4700%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 357.84%. Given that STRATA Skin Sciences, Inc. has higher upside potential than Accuray, Inc., analysts believe STRATA Skin Sciences, Inc. is more attractive than Accuray, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SSKNSTRATA Skin Sciences, Inc.1 0 0 ARAYAccuray, Inc.2 0 0 -
Is SSKN or ARAY More Risky?
STRATA Skin Sciences, Inc. has a beta of 0.448, which suggesting that the stock is 55.193% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.192, suggesting its more volatile than the S&P 500 by 19.162%.
-
Which is a Better Dividend Stock SSKN or ARAY?
STRATA Skin Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. STRATA Skin Sciences, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SSKN or ARAY?
STRATA Skin Sciences, Inc. quarterly revenues are $6.9M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. STRATA Skin Sciences, Inc.'s net income of -$1.6M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, STRATA Skin Sciences, Inc.'s price-to-earnings ratio is -- while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STRATA Skin Sciences, Inc. is 0.03x versus 0.14x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSKNSTRATA Skin Sciences, Inc.0.03x -- $6.9M -$1.6M ARAYAccuray, Inc.0.14x 149.00x $102.2M -$13.8M
-
Which has Higher Returns SSKN or ATRC?
AtriCure, Inc. has a net margin of -23.41% compared to STRATA Skin Sciences, Inc.'s net margin of 1.25%. STRATA Skin Sciences, Inc.'s return on equity of -296.68% beat AtriCure, Inc.'s return on equity of -2.44%.
Company Gross Margin Earnings Per Share Invested Capital SSKNSTRATA Skin Sciences, Inc.60.38% -$0.36 $17.6M ATRCAtriCure, Inc.74.43% $0.04 $568.4M -
What do Analysts Say About SSKN or ATRC?
STRATA Skin Sciences, Inc. has a consensus price target of $7.40, signalling upside risk potential of 4700%. On the other hand AtriCure, Inc. has an analysts' consensus of $49.38 which suggests that it could grow by 59.64%. Given that STRATA Skin Sciences, Inc. has higher upside potential than AtriCure, Inc., analysts believe STRATA Skin Sciences, Inc. is more attractive than AtriCure, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SSKNSTRATA Skin Sciences, Inc.1 0 0 ATRCAtriCure, Inc.4 2 0 -
Is SSKN or ATRC More Risky?
STRATA Skin Sciences, Inc. has a beta of 0.448, which suggesting that the stock is 55.193% less volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.423, suggesting its more volatile than the S&P 500 by 42.295%.
-
Which is a Better Dividend Stock SSKN or ATRC?
STRATA Skin Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. STRATA Skin Sciences, Inc. pays -- of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SSKN or ATRC?
STRATA Skin Sciences, Inc. quarterly revenues are $6.9M, which are smaller than AtriCure, Inc. quarterly revenues of $140.5M. STRATA Skin Sciences, Inc.'s net income of -$1.6M is lower than AtriCure, Inc.'s net income of $1.8M. Notably, STRATA Skin Sciences, Inc.'s price-to-earnings ratio is -- while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STRATA Skin Sciences, Inc. is 0.03x versus 2.76x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSKNSTRATA Skin Sciences, Inc.0.03x -- $6.9M -$1.6M ATRCAtriCure, Inc.2.76x -- $140.5M $1.8M
-
Which has Higher Returns SSKN or ISRG?
Intuitive Surgical, Inc. has a net margin of -23.41% compared to STRATA Skin Sciences, Inc.'s net margin of 27.89%. STRATA Skin Sciences, Inc.'s return on equity of -296.68% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital SSKNSTRATA Skin Sciences, Inc.60.38% -$0.36 $17.6M ISRGIntuitive Surgical, Inc.66.41% $2.21 $18.1B -
What do Analysts Say About SSKN or ISRG?
STRATA Skin Sciences, Inc. has a consensus price target of $7.40, signalling upside risk potential of 4700%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $609.82 which suggests that it could grow by 22.89%. Given that STRATA Skin Sciences, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe STRATA Skin Sciences, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SSKNSTRATA Skin Sciences, Inc.1 0 0 ISRGIntuitive Surgical, Inc.16 10 1 -
Is SSKN or ISRG More Risky?
STRATA Skin Sciences, Inc. has a beta of 0.448, which suggesting that the stock is 55.193% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.658, suggesting its more volatile than the S&P 500 by 65.814%.
-
Which is a Better Dividend Stock SSKN or ISRG?
STRATA Skin Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. STRATA Skin Sciences, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SSKN or ISRG?
STRATA Skin Sciences, Inc. quarterly revenues are $6.9M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. STRATA Skin Sciences, Inc.'s net income of -$1.6M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, STRATA Skin Sciences, Inc.'s price-to-earnings ratio is -- while Intuitive Surgical, Inc.'s PE ratio is 63.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STRATA Skin Sciences, Inc. is 0.03x versus 17.88x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSKNSTRATA Skin Sciences, Inc.0.03x -- $6.9M -$1.6M ISRGIntuitive Surgical, Inc.17.88x 63.01x $2.9B $799.5M
-
Which has Higher Returns SSKN or PSTV?
Plus Therapeutics, Inc. has a net margin of -23.41% compared to STRATA Skin Sciences, Inc.'s net margin of -316.61%. STRATA Skin Sciences, Inc.'s return on equity of -296.68% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SSKNSTRATA Skin Sciences, Inc.60.38% -$0.36 $17.6M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About SSKN or PSTV?
STRATA Skin Sciences, Inc. has a consensus price target of $7.40, signalling upside risk potential of 4700%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1735.78%. Given that STRATA Skin Sciences, Inc. has higher upside potential than Plus Therapeutics, Inc., analysts believe STRATA Skin Sciences, Inc. is more attractive than Plus Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SSKNSTRATA Skin Sciences, Inc.1 0 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is SSKN or PSTV More Risky?
STRATA Skin Sciences, Inc. has a beta of 0.448, which suggesting that the stock is 55.193% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.788, suggesting its less volatile than the S&P 500 by 21.173%.
-
Which is a Better Dividend Stock SSKN or PSTV?
STRATA Skin Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. STRATA Skin Sciences, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SSKN or PSTV?
STRATA Skin Sciences, Inc. quarterly revenues are $6.9M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. STRATA Skin Sciences, Inc.'s net income of -$1.6M is higher than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, STRATA Skin Sciences, Inc.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STRATA Skin Sciences, Inc. is 0.03x versus 4.80x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSKNSTRATA Skin Sciences, Inc.0.03x -- $6.9M -$1.6M PSTVPlus Therapeutics, Inc.4.80x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
50
AXTI alert for Mar 3
AXT, Inc. [AXTI] is down 9.65% over the past day.
Buy
53
AAOI alert for Mar 3
Applied Optoelectronics, Inc. [AAOI] is down 6.93% over the past day.
Sell
32
TPB alert for Mar 3
Turning Point Brands, Inc. [TPB] is down 0.87% over the past day.
